Eiger Biopharmaceuticals Inc ()

Market is closed
Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Propel Bio Management

Leen Kawas And Richard Kayne

4,391,432 $985,876 0.81%
2. 2,100,000 $471,450 -21% 0.03%
3.
Millennium Management

Israel Englander

81,144 $18,217 -70% 0%
4. 14,478 $3,250 0%
5. 10,008 $2,247 0%